Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.

[ad_1]

Optimi Health Corp.

Optimi Wellness Corp.

Halucenex to obtain recently harvested first batch of psilocybe cubensis

Optimi Head of Cultivation, Todd Henderson

Optimi Head of Cultivation, Todd Henderson, navigates Optimi's new fruiting chamber.

Optimi Head of Cultivation, Todd Henderson, navigates Optimi’s new fruiting chamber.

Psilocybin Cubensis

Optimi psilocybin cubensis (liquid culture).

Optimi psilocybin cubensis (liquid society).

VANCOUVER, British Columbia, May 27, 2022 (Globe NEWSWIRE) — Optimi Overall health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company making purely natural, scalable, and available mushroom formulations for transformational human encounters, is pleased to announce that it has entered into a source arrangement with Halucenex Life Sciences Inc. (“Halucenex”), a wholly owned subsidiary of Creso Pharma of Australia (ASX: CPH). Halucenex is centered in Windsor, Nova Scotia and is a lifestyle sciences enterprise targeted on studying novel psychedelic compounds, establishing and licensing psychedelic compounds for the pharmaceutical and nutraceutical markets, and conducting medical trials on the health care advantages of psychedelic drugs.

Also, Optimi needs to verify that the provide arrangement pertains to the entirety of the Company’s not long ago harvested initial batch of psilocybe cubensis mushrooms at its Princeton, British Columbia facility. The mushrooms will be provided to Halucenex in the form of total, dried mushroom fruiting bodies.

“This to start with supply agreement, coming so quickly after our to start with complete cultivation cycle, is a powerful affirmation of our determination to go after the enhancement of organic, GMP psilocybin,” mentioned Bill Ciprick, CEO of Optimi. “From this original proof-of-strategy batch, our cultivation staff will proceed to scale our functions to fulfill the demands of the sector, domestically and internationally with certified entities and for particular person patients inside of Canada according to the phrases of the Distinctive Entry Application.”

Halucenex CEO, Invoice Fleming, says the arrangement with Optimi is a person both businesses will advantage from.

“We’re really psyched to be shifting forward on this source settlement with the staff at Optimi Overall health,” reported Fleming. “Among our prime priorities in the advancement of a psychedelic-assisted psychotherapeutic model for ailments this sort of as anxiety and article-traumatic pressure disorder has been to safe a safe and sound, constant source of GMP psilocybin.”

Authorized get-togethers intrigued in obtaining Optimi psilocybin and practical mushroom items need to deliver an email to [email protected] where a member of the profits staff will respond within just 24 hrs.

ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)

Optimi Well being Inc. is a homegrown, Canadian achievements story making and providing natural, EU-GMP quality psilocybin and practical mushrooms that aim on the well being and wellness markets. Developed with the purpose to make scalable, purely natural mushroom formulations for transformational human encounters, the Company’s aim is to be the amount just one reliable, compassionate supplier of safe and sound, pure GMP grade psilocybin across the environment. With a vertically integrated technique, Optimi intends to cultivate, extract, approach and distribute high good quality purposeful and psychedelic mushroom merchandise at its two services comprising a full of 20,000 square ft in Princeton, British Columbia.

To completely look into the science of mushrooms, the Enterprise has received a exploration exemption beneath Wellness Canada Foodstuff and Drug Regulations (FDR) for the use of psilocybin and psilocin for scientific uses by way of its wholly owned subsidiary Optimi Labs Inc. Optimi has also been granted a dealer’s license below Canada’s Narcotic Control Regulations governing possession, distribution, sale, laboratory analysis of and research and progress of psilocybin and psilocin formulations. Optimi is committed to qualified cultivation and top quality generation subject to and in accordance with the terms of all applicable legislation and governing rules to assure harmless, top-quality Canadian fungi creation.

Optimi was a short while ago granted an amendment to its Dealer’s Licence by Overall health Canada, allowing the Organization to have a quota of up to 5000kg of dried psilocybin mushrooms –
the equivalent of 10kg of psilocybin – and 100g of psilocin.

ABOUT HALUCENEX

Halucenex operates a 6000 sq ft health care facility in Windsor, Nova Scotia with 6 treatment method rooms and a safe laboratory dedicated to executing psychedelic-assisted psychotherapy and scientific exploration. Halucenex intends to maintain command around all areas of the product or service improvement system – mycological exploration, extraction know-how, and synthetic formulation as perfectly as drug supply systems, psychedelic-assisted psychotherapy and regulatory affairs.

Clinically, Halucenex is centered on exploring psilocybin, psilocybin-derivatives, and other psychedelic medication for the applications of dealing with customers struggling from PTSD and anxiety applying its complete psilocybin-assisted psychotherapy treatment model. Halucenex is committed to advancing the science about the use of psilocybin in psychedelic-assisted psychotherapy by:

For extra information and facts or to request an job interview, make sure you get in touch with:

Michael Kydd
Media & Stakeholder Relations Advisor
E mail: [email protected]
Cell phone: +1 (902) 880 6121

FORWARD‐LOOKING STATEMENTS

This information launch has forward‐looking statements and forward‐looking information inside of the indicating of Canadian securities laws (collectively, “forward‐looking statements”) that relate to Optimi’s latest expectations and sights of long run situations. Any statements that express, or involve conversations as to, expectations, beliefs, ideas, goals, assumptions or foreseeable future functions or overall performance (normally, but not normally, as a result of the use of phrases or phrases these kinds of as “will most likely final result,” “are envisioned to,” “expects,” “will continue on,” “is anticipated,” “anticipates,” “believes,” “estimated,” “intends,” “plans,” “forecast,” “projection,” “strategy,” “objective,” and “outlook”) are not historical points and could be forward‐looking statements and might include estimates, assumptions and uncertainties which could lead to precise outcomes or results to differ materially from these expressed in this kind of forward‐looking statements. No assurance can be presented that these expectations will demonstrate to be proper and these kinds of forward‐looking statements bundled in this news launch should not be unduly relied on. These statements communicate only as of the day of this news release. In individual and without the need of limitation, this news release has forward‐ seeking statements pertaining to pursuits proposed to be conducted under the Company’s dealer’s license and linked small business similar to psilocybin and psilocin and Optimi’s strategies, emphasis and aims.

Forward‐looking statements are dependent on a selection of assumptions and are subject to a amount of threats and uncertainties, lots of of which are over and above Optimi’s management, which could induce genuine effects and events to vary materially from all those that are disclosed in or implied by such forward‐looking statements. These threats and uncertainties contain, but are not constrained to, the affect and progression of the COVID‐19 pandemic and other factors set forth underneath “Forward‐Looking Statements” and “Risk Factors” in the Company’s Annual information Type dated January 12, 2022, and other continuous disclosure filings out there beneath Optimi’s profile at www.sedar.com. Optimi undertakes no obligation to update or revise any forward‐looking statements, whether as a outcome of new information and facts, potential situations or usually, apart from as may well be essential by legislation. New elements arise from time to time, and it is not doable for Optimi to predict all of them or assess the impact of each and every this kind of factor or the extent to which any aspect, or blend of things, may possibly cause success to vary materially from individuals contained in any forward‐looking assertion.

Any forward‐looking statements contained in this information launch are expressly certified in their entirety by this cautionary assertion.

Photos accompanying this announcement are obtainable at
https://www.globenewswire.com/NewsRoom/AttachmentNg/b1df7352-0b4b-48e9-a3f1-950de89cd66a

https://www.globenewswire.com/NewsRoom/AttachmentNg/82589a86-5ae3-4399-b33e-5b4b9927bcb4

[ad_2]

Resource backlink